Denied a mortuary van, tribal man walks 10 km carrying wife's body

Madikeri, Apr 27: Four labourers, who were travelling to Kerala via Makutta on foot, were stopped by Karnataka Forest Department officials and handed over to police.

Police said on Monday that the labourers identified as Anish, Radhakrishna, Shrinil and Prabhakar, who were working in the Coffee plantations in Chembellur and Ontiyangadi. As the roads to Kerala were sealed following lockdown, they were held up in the district.

The forest guards, who spotted them walking through the forest area, brought them back to the town as per the directions of the higher officials last evening. DCF Shivashankar, ACF Konerira Roshni and Ranger Arun Kumar were present.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Mangaluru, July 14: In order to detect COVID-19 cases quickly in Dakshina Kannada, the government has commissioned a programme to administer rapid antigen tests.

The coastal district has already received 3,500 rapid antigen test kits, which can give results in 30 minutes, an official said, adding that tests will be conducted shortly and training is being imparted on the use of the kits.

The antigen tests will be conducted for emergency cases like delivery, surgery, persons with severe symptoms of Covid-19, multiple-organ failure and for those whose condition is critical. 

"If a symptomatic patient tests negative for Covid-19, then his throat swab sample would be sent for lab testing," the district health officer (DHO) said.

The rapid antigen tests is expected to help in increasing the number of tests and bring down the load of testing on labs, as antigen kits allow faster diagnosis.

It takes a minimum of eight hours to get the results via real-time polymerase chain reaction (RT-PCR) test. Antigen tests can provide results within half an hour.